Corium logo

Corium

Corium is a biopharmaceutical company leading the development, manufacturing, and commercialization of CNS therapies.

359 employees · est. 1999 · Boston, United States

VS
Myogen logo

Myogen

Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs.

est. 1996

Myogen is the older company (1999 vs 1996).

Side-by-Side Comparison

Corium Myogen
Founded
1999 1996 older
Headquarters
Boston, United States Not tracked yet
Employees
359 Not tracked yet
Industry
Biopharma, Health Care, Pharmaceutical Biopharma, Biotechnology, Health Care
Funding Stage
Private Equity Series D
Total Funding
Not tracked yet $187.77M
Funding Rounds
1 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical, CNS Therapies, Commercial-stage, Development, Commercialization, Pharmaceutical, Consumer Product, Healthcare Therapies, Clinicians, Patients, Families, Caregivers, Track Record Biopharmaceutical Company, Cardiovascular Health, Small Molecule Therapeutics, Discovery, Development, Commercialization, Clinical Expertise, Cardiovascular Disorders, Biology Of Cardiovascular Disease, Clinical Development Expertise, Novel Therapies, Licensing, Acquisition, Unmet Medical Needs
Website
corium.com myogen.com
Corium logo

About Corium

Corium is a biopharmaceutical company that has been leading the development, manufacturing, and commercialization of central nervous system (CNS) therapies since 1999. The company collaborates with some of the world's largest pharmaceutical and consumer product companies to take products from concep...

Myogen logo

About Myogen

Myogen is a biopharmaceutical company founded in 1996, dedicated to advancing cardiovascular health with innovative small molecule therapeutics. Their slogan "Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs" reflects their mission. The company focu...

We will tell you when either one moves

BounceWatch watches Corium and Myogen for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Corium and Myogen — by email.

Frequently Asked Questions

Corium — Corium is a biopharmaceutical company leading the development, manufacturing, and commercialization of CNS therapies.. Myogen — Advancing cardiovascular health with innovative small molecule therapeutics for unmet medical needs.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Corium has raised undisclosed funding while Myogen has raised $187.77M.
Corium and Myogen operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Corium with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Corium on 12 Sep 2024, and Myogen on 26 Jul 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy